Danger Zone: Valeant Pharmaceuticals

Since our initial warning on Valeant in June 2014, the stock is down nearly 35%. The stock performance is even worse over the short term, having fallen 68% since August 2015. After such a drastic price decline, one might think shares are a bargain.